IndiaMTF — home
Stock

Divi's Laboratories — MTF Book

DIVISLAB · Divi's Laboratories Limited
Health Technology

Daily Margin Trading Facility book for Divi's Laboratories across NSE and BSE, from 01 Aug 2017. All figures in ₹ crore, derived from exchange public disclosures.

What is Divi's Laboratories’s MTF book?

Divi's Laboratories Limited (DIVISLAB) has ₹349 crore funded under Margin Trading Facility across NSE and BSE as of 26 Oct 2026 — 0.23% of India’s MTF book, ranking #89. Over 1M (the last 30 trading days) the funded value has risen 34.8%, with the number of shares under margin up 29.4%.

Funded value
₹349 Cr
as of 26 Oct 2026
Rank in book
#89
2,237 days tracked
Share of book
0.23%
of the whole NSE + BSE book
Peak funded
₹365 Cr
on 01 Oct 2026
Largest single-day addition
+₹45 Cr
on 12 Aug 2026
Largest single-day unwind
−₹36 Cr
on 12 Oct 2026
Free-float market cap
₹1,15,608 Cr
full market cap ₹2,40,249 Cr · 48.1% free float · Large cap
MTF share of free float
0.30%
1.0× the median large cap · 0.4× the Health Technology median

Share of free float on margin, month by month

Shares under margin at each month-end as a share of free-float shares, using that month-end’s share count and the free-float filing public at the time. It counts shares, not value, so a price move does not move it by itself.

0.01%0.13%0.24%0.35%Feb 2024Oct 2026
View as table: share of free float on margin33 months
Month-end% of free float
26 Oct 20260.305%
30 Sep 20260.315%
31 Aug 20260.224%
31 Jul 20260.119%
30 Jun 20260.117%
29 May 20260.099%
30 Apr 20260.112%
30 Mar 20260.137%
27 Feb 20260.167%
30 Jan 20260.187%
31 Dec 20250.155%
28 Nov 20250.161%
31 Oct 20250.128%
30 Sep 20250.192%
29 Aug 20250.154%
31 Jul 20250.129%
30 Jun 20250.095%
30 May 20250.075%
30 Apr 20250.073%
28 Mar 20250.071%
28 Feb 20250.072%
31 Jan 20250.084%
31 Dec 20240.087%
29 Nov 20240.103%
31 Oct 20240.054%
30 Sep 20240.062%
30 Aug 20240.062%
26 Jul 2024†0.056%
28 Jun 20240.059%
31 May 20240.062%
30 Apr 20240.128%
28 Mar 20240.267%
29 Feb 20240.313%

† Not the month’s last trading day: the last day the stock was in the archive that month (before 11 Nov 2025 the archive kept only the 500 largest positions).

Dated events

NSE & BSE split

How DIVISLAB’s funded book divides across the two exchanges, as of 26 Oct 2026.
NSE
NSE ₹343 Cr · 98.3%BSE ₹6 Cr · 1.7%

MTF vs Price

Margin-funded outstanding for DIVISLAB in ₹ crore against the closing price, adjusted for splits and bonuses. Each window uses the same reference date as the table below, so the two agree. Funded value moves with the price on its own, so the line under the chart reads the share count instead — that is what shows whether more stock is genuinely being borrowed against.
MTF book (₹ Cr)

Price and liquidity

Adjusted for splits and bonuses, so a change across a corporate action reflects the market rather than the share count.
Last close
₹8,950.00
as of 23 Oct 2026
Price, 1M
−5.7%
adjusted for splits and bonuses
Delivery, 20-day avg
64.2%
of traded volume actually settled
Sessions to unwind
1
of average deliverable volume
Shares under margin divided by average daily deliverable volume over the last 20 sessions.

Book, shares and price by window

Funded value moves with the price on its own, so the share count is what shows whether more stock is actually being borrowed against. The last column reads the two together.
WindowBook ΔBook %SharesPriceReading
1D+₹10+2.9%+2.9%
+10,816
+0.0%building as it falls
10D−₹1−0.3%−0.1%
−206
−4.2%unwinding as it falls
1M+₹90+34.8%+29.4%
+88,439
−5.7%building as it falls
3M+₹237+212.2%+142.5%
+2,28,797
+23.5%building into strength
6M+₹242+224.7%+131.6%
+2,21,231
+40.7%building into strength
1Y+₹238+213.9%+126.9%
+2,17,779
+35.8%building into strength

Shares under margin

Number of shares funded via MTF over time (NSE + BSE combined).

Rank trajectory

Where DIVISLAB has sat in the funded-value ranking each day (1 = most funded). Lower is more prominent.

DIVISLAB — last 30 trading days

Combined NSE + BSE funded value, day-on-day change, share of the whole book, and rank. Newest first.
DateCombined (₹ Cr)Day Δ (₹ Cr)% of bookRank
26 Oct 2026349+₹100.23%89
23 Oct 2026339+₹60.22%95
22 Oct 2026334−₹60.22%97
21 Oct 2026339−₹40.22%96
19 Oct 2026343−₹20.22%96
16 Oct 2026345−₹100.22%95
15 Oct 2026355+₹130.23%93
14 Oct 2026342+₹190.22%96
13 Oct 2026322+₹80.21%103
12 Oct 2026314−₹360.20%108
09 Oct 2026350+₹40.23%94
08 Oct 2026346+₹140.22%95
07 Oct 2026332+₹20.21%101
06 Oct 2026330−₹350.21%101
05 Oct 2026364−₹10.23%92
01 Oct 2026365+₹70.23%93
30 Sep 2026358+₹30.23%93
29 Sep 2026355+₹120.22%93
28 Sep 2026343+₹100.22%94
25 Sep 2026333+₹140.21%99
24 Sep 2026319+₹30.20%108
23 Sep 2026316−₹20.20%105
22 Sep 2026318+₹110.20%102
21 Sep 2026307+₹70.20%114
18 Sep 2026300+₹20.19%116
17 Sep 2026298+₹180.19%117
16 Sep 2026280+₹00.18%122
15 Sep 2026280+₹50.18%125
11 Sep 2026275+₹90.18%128
10 Sep 2026266—0.17%132

DIVISLAB within Health Technology

Ranked #6 of 61 funded Health Technology stocks, carrying 5.3% of that sector’s margin book. Its 0.30% of free float on margin is 0.3× the sector median of 0.89%. Nearest names by funded value:
#StockMTF book (₹ Cr)% of sector% of free floatBook, 1M
4ANURASAnupam Rasayan India₹4306.5%7.72%+13.0%
5VIYASHViyash Scientific₹4216.4%7.34%−16.0%
6DIVISLABDivi's Laboratories₹3495.3%0.30%+34.8%
7SUNPHARMASun Pharmaceutical Industries₹2764.2%0.13%−1.6%
8NATCOPHARMNatco Pharma₹1722.6%1.78%−8.7%

All Health Technology stocks and how the sector has moved →

Disclaimer. Data sourced from daily margin trading disclosure provided by NSE and BSE. This website and page are meant for educational and information only — not investment advice. MTF is leveraged and can amplify losses. Rules, margins, rates and eligible-stock lists change; verify current details with your broker and SEBI/exchange circulars. IndiaMTF.com is not a SEBI-registered intermediary, broker, or investment adviser and has no affiliation with SEBI, NSE or BSE. Figures are reproduced from publicly disclosed exchange data, may be delayed or revised, and should be independently verified before any trading decision. Consult a SEBI-registered investment adviser before investing.